Breaking: 23andMe Gets OK to Sell Breast Cancer Gene Test; No Prescription Needed

Julie Steenhuysen : Mar 6, 2018
Reuters

[Reuters/CNBC.com] Genetic testing company 23andMe on Tuesday won U.S. Food and Drug Administration approval to sell genetic tests for three key breast cancer mutations directly to consumers, a coup for the company that has been gradually winning approval for such tests after FDA banned its Personal Genome Service in 2013... Click here to read. (Photo: Lab/Creative Commons/via Pixabay)